Oseltamivir Phosphate Powder, For Suspension
NDC Package 76420-924-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Oseltamivir Phosphate powders is oseltamivir is used to treat symptoms caused by the flu virus (influenza). This formulation utilizes a powder, for suspension delivery system. Marketed by Asclemed Usa, Inc., this product is identified by NDC 76420-924 and is authorized under FDA application ANDA208347.

Identification & Billing

NDC Package Code
76420-924-60
Package Description
1 BOTTLE, GLASS in 1 CARTON / 60 mL in 1 BOTTLE, GLASS
Product Code
76420-924
11-Digit Billing Format
76420092460
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Oseltamivir Phosphate
Non-Proprietary Name
Oseltamivir Phosphate
Substance Name
Oseltamivir Phosphate
Dosage Form
Powder, For Suspension - An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle).
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
OSELTAMIVIR PHOSPHATE 6 mg/mL
Pharmacologic Class
Usage Information
Oseltamivir is used to treat symptoms caused by the flu virus (influenza). It helps make the symptoms (such as stuffy nose, cough, sore throat, fever/chills, aches, tiredness) less severe and shortens the recovery time by 1-2 days. This medication may also be used to prevent the flu if you have been exposed to someone who already has the flu (such as a sick household member) or if there is a flu outbreak in the community. Talk to your doctor for more details. This medication works by stopping the flu virus from growing. It is not a substitute for the flu vaccine. (See also Notes section.)

Regulatory & Marketing

Labeler Name
Asclemed Usa, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA208347
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-21-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76420-924-60 identifies a specific commercial package of 1 bottle, glass in 1 carton / 60 ml in 1 bottle, glass of Oseltamivir Phosphate, a human prescription drug labeled by Asclemed Usa, Inc.. This powder, for suspension is formulated for oral use and contains oseltamivir phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Asclemed Usa, Inc. on February 21, 2018. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Oseltamivir is used to treat symptoms caused by the flu virus (influenza). It helps make the symptoms (such as stuffy nose, cough, sore throat, fever/chills, aches, tiredness) less severe and shortens the recovery time by 1-2 days. This medication may also be used to prevent the flu if you have been exposed to someone who already has the flu (such as a sick household member) or if there is a flu outbreak in the community. Talk to your doctor for more details. This medication works by stopping the flu virus from growing. It is not a substitute for the flu vaccine. (See also Notes section.)

How is this Asclemed Usa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76420092460. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76420-924-60
11-Digit CMS (5-4-2)
76420-0924-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.